Details

Autor(en) / Beteiligte

• Izbicki, Gabriel
• Teo, Valerie
• Liang, Jenifer
• Russell, Grant M
• Holland, Anne E
• Zwar, Nicholas A
• Bonevski, Billie
• Mahal, Ajay
• Eustace, Paula
• Paul, Eldho
• Phillips, Kirsten
• Wilson, Sally
• George, Johnson
• Abramson, Michael J

Titel

Clinical Characteristics Of Patients With Asthma COPD Overlap (ACO) In Australian Primary Care

Ist Teil von

• International journal of chronic obstructive pulmonary disease, 2019-01, Vol.14, p.2745-2752

Ort / Verlag

New Zealand: Dove Medical Press Limited

Erscheinungsjahr

2019

Quelle

MEDLINE

Beschreibungen/Notizen

• Many older adults with a history of smoking and asthma develop clinical features of both asthma and COPD, an entity sometimes called asthma-COPD overlap (ACO). Patients with ACO may be at higher risk of poor health outcomes than those with asthma or COPD alone. However, understanding of ACO is limited in the primary care setting and more information is needed to better inform patient management. We aimed to compare the characteristics of patients with ACO or COPD in Australian general practices. Data were from the RADICALS (Review of Airway Dysfunction and Interdisciplinary Community-based care of Adult Long-term Smokers) trial, an intervention study of an interdisciplinary community-based model of care. Baseline demographic and clinical characteristics, pre- and post-bronchodilator spirometry, dyspnoea and St. George's Respiratory Questionnaire scores were compared between 60 ACO patients and 212 with COPD alone. Pre-bronchodilator Forced Expiratory Volume in 1 second (mean±SD 58.4±14.3 vs 67.5±20.1% predicted) and Forced Vital Capacity (mean 82.1±16.9 v 91.9±17.2% predicted) were significantly lower in the ACO group (p<0.001), but no difference was found in post-bronchodilator spirometry. Demographic and clinical characteristics, dyspnoea, quality of life, comorbidities and treatment prescribed did not differ significantly between groups. This is the first study describing the clinical characteristics of ACO patients in Australian general practices. Our finding of lower pre-bronchodilator lung function in the ACO group compared to those with COPD reinforces the importance of spirometry in primary care to inform management. Australian New Zealand Clinical Trials Registry ACTRN12614001155684.